Sanara MedTech Inc. SMTI
35.06
(0.04)
(0.11%)
as of 25 Sep
- Market cap
- $322.5M
- P/E
- 0.0×
Follow SMTI
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (147.79%) | (153.71%) | (167.53%) | (164.45%) |
+8 more TTM periods Free account |
|
| (38.13%) | (40.54%) | (46.65%) | (46.97%) | ||
ROIC |
13.49% | 14.38% | 12.92% | 19.20% | |
Return on Tangible Assets |
(159.01%) | (186.99%) | (244.35%) | (262.45%) | |
Average Days of Receivables |
41.79 | 46.24 | 42.47 | 43.30 | |
Free Cash Flow per Share |
0.52 | 0.39 | 0.25 | (0.10) | |
Free Cash Flow |
4.50 | 3.37 | 2.17 | (0.83) | |
Capital Expenditures |
(1.19) | (2.95) | (4.61) | (4.60) | |
Piotroski F-Score |
5.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
8.15% | 9.46% | 9.91% | 5.70% | |
Accounts Receivable Turnover |
8.94 | 8.42 | 8.44 | 8.78 | |
Accounts Payable Turnover |
5.29 | 4.98 | 3.89 | 6.03 | |
Inventory Turnover |
2.20 | 2.42 | 2.24 | 2.47 | |
Average Days of Payables |
66.83 | 44.19 | 113.50 | 53.95 | |
Days of Inventory on Hand |
165.00 | 149.69 | 191.63 | 156.53 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4.53% | 4.54% | 4.92% | 3.09% | |
Selling, General and Administrative Expense of Revenue |
76.89% | 75.80% | 76.34% | 76.31% | |
Share Based Compensation of Revenue |
4.50% | 4.54% | 5.00% | 5.07% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.18) | (0.19) | (0.18) | (0.10) | |
Depreciation/Fixed assets |
7.51 | 8.07 | 9.25 | 12.35 | |
Capex/Depreciation |
(0.37) | (0.80) | (1.09) | (0.89) | |
Revenue per Share |
12.68 | 12.34 | 11.96 | 11.78 | |
Operating CF per Share |
0.66 | 0.73 | 0.79 | 0.44 | |
Capex per Share |
(0.14) | (0.34) | (0.53) | (0.53) | |
Capex to Sales |
0.01 | 0.03 | 0.04 | 0.05 | |
Net Profit Margin |
(29.15%) | (31.24%) | (36.43%) | (36.80%) |
Columns are period end dates